Measurable Residual Disease Results After Consolidation Therapy Predictive of Relapse in Pediatric Leukemia
TUESDAY, Sept. 24, 2024 (HealthDay News) — For children with acute lymphoblastic leukemia...
Read More
Search Physician’s Weekly
Search for articles, editorials, meeting coverage, podcasts, and more
Showing 1 - 20 of 1884 results for 'leukemia'
Flow cytometric immunophenotypic features of acute myeloid leukemia with mast cell differentiation.
Acute myeloid leukemia (AML) with mast cell (MC) differentiation was recently described as an aggressive subgroup of AML cases. The objectives of this study were to assess the flow cytometric immunophenotypic features of AML-MC...
Read More
Acute Leukemia Tied to Various Ocular Manifestations
Patients with newly diagnosed acute myeloid leukemia and acute lymphoblastic leukemia experienced various ocular manifestations, such as retinal hemorrhage.
Read MoreCausal Relationship Between Gut Microbiota and Leukemia: Future Perspectives.
The gut microbiota plays a crucial role in maintaining homeostasis in the human gastrointestinal tract. Numerous studies have shown a strong association between the gut microbiota and the emergence and progression of various...
Read More
Genetic Subtype, Genomic Alterations Linked to Relapse in Leukemia
THURSDAY, Aug. 22, 2024 (HealthDay News) — Genetic subtype, aneuploidy patterns, and genomic...
Read More
Pharmacogenomic Score Can Personalize Treatment of Leukemia in Children
WEDNESDAY, Aug. 7, 2024 (HealthDay News) — For pediatric patients with acute myeloid...
Read More
#VisualAbstract: Blinatumomab Improves Survival in MRD-Negative Acute Lymphoblastic Leukemia in Adults
Click here to read this study in NEJM. ©2024 2 Minute Medicine, Inc. All rights reserved. No...
Read More
Blinatumomab + Chemo Ups Survival in B-Cell Precursor Acute Lymphoblastic Leukemia
MONDAY, July 29, 2024 (HealthDay News) — For adult patients with B-cell precursor acute...
Read More
Ophthalmologic Manifestations of Acute Leukemia Are Heterogeneous, Detectable at Initial Presentation or Relapse
Ophthalmologic manifestations of acute leukemia are heterogeneous and detectable at initial...
Read MoreAdvertisement
Zanubrutinib Plus Venetoclax Shows Promise in Del(17p)/TP53-Mutated Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma
Zanubrutinib plus venetoclax delivered promising preliminary efficacy results in newly diagnosed CLL/SLL in participants with del(17p) and/or TP53 mutations.
Read More
Revumenib Displays Encouraging Anti-Tumor Activity in KMT2Ar Acute Leukemia, AUGMENT-101 Trial Stopped Early
The AUGMENT-101 trial in patients with in KMT2Ar leukemia has been stopped early because of revumenib encouraging anti-tumor activity.
Read MoreImproving prediction of blood cancer using leukemia microarray gene data and Chi2 features with weighted convolutional neural network.
Blood cancer has emerged as a growing concern over the past decade, necessitating early diagnosis for timely and effective treatment. The present diagnostic method, which involves a battery of tests and medical experts, is...
Read MoreCrosstalk between genomic variants and DNA methylation in FLT3 mutant acute myeloid leukemia.
Acute myeloid leukemia (AML) is a type of blood cancer with diverse genetic variations and DNA methylation alterations. By studying the interaction of gene mutations, expression, and DNA methylation, we aimed to gain valuable...
Read More
Posttransplant Cyclophosphamide GVHD Prophylaxis Beneficial in Leukemia
MONDAY, June 24, 2024 (HealthDay News) — For patients with acute myeloid leukemia (AML)...
Read More
Personalized ddPCR Monitoring Enables Prompt Leukemia Treatment Decisions
Personalized ddPCR monitoring of rare genetic alterations can help clinicians make timely treatment decisions for patients with leukemia, according to research.
Read More
Trametinib Safe and Effective for Relapsed or Refractory Juvenile Myelomonocytic Leukemia
For children with relapsed or refractory juvenile myelomonocytic leukemia (JMML), trametinib is...
Read More
AI and ML Show Promise in Targeting Therapies for Chronic Lymphocytic Leukemia
AI and ML advances chronic lymphocytic leukemia therapies.
Read More
ASCO: Asciminib Has Superior Efficacy to TKIs for Newly Diagnosed Leukemia
WEDNESDAY, June 5, 2024 (HealthDay News) — For patients with newly diagnosed chronic myeloid...
Read More
#VisualAbstract: Ponatinib is Superior to Imatinib in Frontline Philadelphia Chromosome-Positive Acute Lymphoblastic Leukemia
Click here to read this study in JAMA. ©2024 2 Minute Medicine, Inc. All rights reserved. No...
Read More
Leukemia Biology Debate: AML Focus
Research presented at the fourth European Congress Controversies in Leukemia and how this new information has changed the landscape for patients with acute myeloid leukemia.
Read More